Clinical Trials Day

Investor Relations

Many of the present Contract Research Organizations are looking for funding through venture capital routes and have the opportunity to pitch to investors. Investment via development deals with CRO’s is also an important route for company development and Sanjeevani provides the perfect platform to start negotiations.

The company has a commitment to investor relations and education regarding its strategy and how sustainable and responsible business practices benefit the companys reputation, employee retention, global visibility, and return on investment opportunity.The company’s transformation to a next-generation BioPharma service provider includes a stronger alignment with commitment and sustainable business practices, which is one of the reasons why Sanjeevani earned the good number of clients and brand in the Indian market.

INVESTMENT HIGHLIGHTS

Strong management and board experience in Clinical Research with drug regulatory approvals worldwide.
Focus on profitability in Western and Asia-Pacific markets and emerging economy populations for large product volume and financial return.